Bax mRNA therapy using cationic liposomes for human malignant melanoma
Abstract
Background: Bax is a pro‐apoptotic molecule that functions as a tumor suppressor and Bax gene therapy has been examined for various cancers. Gene transfer by mRNA lipofection is more efficient than plasmid DNA lipofection and, in the present study, we examined the anti‐tumor effects in human malignant melanoma cells (HMGs) using Bax mRNA lipofection. Methods: Bax protein expression, cell growth inhibition, caspase‐3 activity and apoptosis were examined in vitro. Liposome‐Bax mRNA was applied locally once every 5 days for a total of five times to peripheral HMG tumors transplanted in nude mice. Tumor growth inhibition was evaluated by measuring the tumor volume and apoptosis was detected using a terminal deoxynucleotidyl transferase‐mediated dUTP nick end labelling (TUNEL) assay. Results: Enhanced expression of Bax protein was observed following Bax mRNA transfer and cell survival was 59.8%. Caspase‐3 activity and TUNEL‐positive cells increased significantly following Bax mRNA lipofection compared to Bax plasmid transfer. In mice, tumor growth increased only slightly during liposome‐Bax mRNA administration and the tumor volume on day 30 (10 days after completion of administration) was 36.7% of that in the saline control group. By contrast, Bax plasmid transfection resulted in little change in tumor growth compared to controls. Conclusions: Bax mRNA therapy using liposomes has stronger anti‐tumor effects than Bax gene therapy using a plasmid, and the results suggest that Bax mRNA lipofection may be a viable treatment for malignant melanoma. Copyright © 2008 John Wiley & Sons, Ltd.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Regulation of other tumour-associated genes, such as PLK1, Bax, Maspin, PUMA and PTEN, can delay tumour growth in vivo.
“Similarly, the regulation of other tumour-associated genes, such as PLK1 (ref.133), Bax219, Maspin37, PUMA70 and PTEN220, can delay tumour growth in vivo.”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [219]
Cites
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289 · see citing works
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003 · see citing works
Zou, H., Henzel, W. J., Liu, X., Lutschg, A., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80501-2 · Cited by 3,145 · see citing works
Cancer regression in patients after transfer of genetically engineered lymphocytes
Morgan, R. A., Dudley, M. E., Wunderlich, J. R., Hughes, M. S., Yang, J. C., Sherry, R. M., Royal, R. E., Topalian, S. L., Kammula, U. S., Restifo, N. P., et al. (2006) · Science · doi:10.1126/science.1129003 · Cited by 2,603 · see citing works
Shimizu, S., Narita, M., Tsujimoto, Y., & Tsujimoto, Y. (1999) · Nature · doi:10.1038/20959 · Cited by 2,178 · see citing works
Bax and Adenine Nucleotide Translocator Cooperate in the Mitochondrial Control of Apoptosis
Marzo, I., Brenner, C., Zamzami, N., Jürgensmeier, J. M., Susin, S. A., Vieira, H. L. A., Prévost, M.-C., Xie, Z., Matsuyama, S., Reed, J. C., et al. (1998) · Science · doi:10.1126/science.281.5385.2027 · Cited by 1,168 · see citing works
Gene Therapy Death Prompts Review of Adenovirus Vector
Marshall, E. (1999) · Science · doi:10.1126/science.286.5448.2244 · Cited by 918 · see citing works
Cationic liposome-mediated RNA transfection.
Malone, R. W., Felgner, P. L., & Verma, I. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6077 · Cited by 911 · see citing works
(2001) · PubMed Central · Cited by 342 · see citing works
Check, E. (2002) · Nature · doi:10.1038/420116a · Cited by 291 · see citing works
Bettinger, T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.18.3882 · Cited by 224 · see citing works
Mockey, M., Gonçalves, C., Dupuy, F. P., Lemoine, F. M., Pichon, C., & Midoux, P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.105 · Cited by 165 · see citing works
Mockey, M., Bourseau, E., Voshavar, C., Chaudhuri, A., Lafosse, S., Cam, É. L., Quesniaux, V. F. J., Ryffel, B., Pichon, C., & Midoux, P. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701072 · Cited by 161 · see citing works
Dual Interactions of the Translational Repressor Paip2 with Poly(A) Binding Protein
Khaleghpour, K., Kahvejian, A., Crescenzo, G. D., Roy, G., Svitkin, Y. V., Imataka, H., O'Connor‐McCourt, M. D., & Sonenberg, N. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.5200-5213.2001 · Cited by 159 · see citing works
Hess, P. R., Boczkowski, D., Nair, S. K., Snyder, D. J., & Gilboa, E. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0064-z · Cited by 113 · see citing works
Kellis, M., Marani, M., Yu, J., et al. (2001) · PubMed · Cited by 90 · see citing works
Lu, D., Benjamin, R., Kim, M., Conry, R. M., & Curiel, D. (1994) · PubMed · Cited by 89 · see citing works
p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome
Nakase, M., Inui, M., Okumura, K., Kamei, T., Nakamura, S., & Tagawa, T. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0196 · Cited by 72 · see citing works
Self-citationTrial halted after gene shows up in semen
Boyce, N. (2001) · Nature · doi:10.1038/414677a · Cited by 62 · see citing works
Arafat, W. O., Gómez-Navarro, J., Xiang, J., Barnes, M. N., Mahasreshti, P. J., Alvarez, R. D., Siegal, G. P., Badib, A. O., Buchsbaum, D. J., Curiel, D. T., et al. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0071 · Cited by 55 · see citing works
Kobayashi, T., Sawa, H., Morikawa, J., Zhang, W., & Shiku, H. (2000) · Japanese journal of cancer research : Gann · doi:10.1111/j.1349-7006.2000.tb00913.x · Cited by 52 · see citing works
Antitumor Activity of bax and p53 Naked Gene Transfer in Lung Cancer: In Vitro and In Vivo Analysis
Coll, J., NEGOESCU, A., Louis, N., et al. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.14-2063 · Cited by 52 · see citing works
Bax-Induction Gene Therapy of Pancreatic Cancer
Pirocanac, E. C., Nassirpour, R., Yang, M., Wang, J., Nardin, S. R., Gu, J. H., Fang, B., Moossa, A. R., Hoffman, R. M., & Bouvet, M. (2002) · Journal of Surgical Research · doi:10.1006/jsre.2002.6473 · Cited by 40 · see citing works
Tsunemitsu, Y., Kagawa, S., Tokunaga, N., et al. (2004) · Gut · doi:10.1136/gut.2003.021683 · Cited by 36 · see citing works
An adenovirus encoding proapoptotic Bax synergistically radiosensitizes malignant glioma
Arafat, W. O., Buchsbaum, D. J., mez-Navarro, J. G., Tawil, S. A., Olsen, C. C., Xiang, J., El-Akad, H., Salama, A. M., Badib, A. O., Stackhouse, M. A., et al. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04488-7 · Cited by 36 · see citing works
Yanagihara, K., Cheng, H., & Cheng, P. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700092 · Cited by 36 · see citing works
[43] Cationic liposome-mediated RNA transfection
Dwarki, V., Malone, R. W., & Verma, I. M. (1993) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(93)17093-k · Cited by 34 · see citing works
Lectin enhancement of the lipofection efficiency in human lung carcinoma cells
Yanagihara, K., & Cheng, P. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00100-2 · Cited by 30 · see citing works
Bax-Induced Apoptosis as a Novel Gene Therapy Approach for Carcinoma of the Cervix
Huh, W. K., Gómez-Navarro, J., Arafat, W. O., et al. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6403 · Cited by 28 · see citing works
Ryuke, Y., Mizuno, M., Natsume, A., et al. (2003) · Melanoma Research · doi:10.1097/00008390-200308000-00003 · Cited by 19 · see citing works
Bax is an important determinant for radiation sensitivity in esophageal carcinoma cells.
Kim, R., Inoue, H., & Toge, T. (2004) · International Journal of Molecular Medicine · doi:10.3892/ijmm.14.4.697 · Cited by 16 · see citing works
Guo, B., Yin, M. B., Tóth, K., et al. (1999) · PubMed · Cited by 16 · see citing works
Zhao, Y., Xiao, B., Chen, B., et al. (2000) · PubMed · Cited by 14 · see citing works
Primary malignant melanoma of the oral cavity. Case report and establishment of melanoma cell line.
TAGAWA, T., Yatani, R., Nishioka, H., et al. (1981) · PubMed · Cited by 11 · see citing works
Self-citationKobayashi, T., Sawa, H., Morikawa, J., et al. (2002) · International Journal of Oncology · doi:10.3892/ijo.20.4.723 · Cited by 10 · see citing works
Bax gene therapy for human osteosarcoma using cationic liposomes in vivo
Okumura, K., Nakase, M., Nakamura, S., et al. (2007) · Oncology Reports · doi:10.3892/or.17.4.769 · Cited by 9 · see citing works
Self-citationOkumura, K., Nakase, M., Nakamura, S., et al. (2005) · International Journal of Oncology · doi:10.3892/ijo.27.2.433 · Cited by 5 · see citing works
Self-citation赵燕秋, 肖冰, 陈宝军, et al. (2000) · 中华医学杂志:英文版 · Cited by 4 · see citing works
Ronai, Z. A., Polotskaya, A., Gradia, S., Amin, S. G., & Hecht, S. S. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960703)67:1 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Lipid nanoparticles for mRNA delivery
Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076 · see citing works
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474 · see citing works
Wang, J.-H., Forterre, A. V., Zhao, J., Frimannsson, D. O., Delcayre, A., Antes, T. J., Efron, B., Jeffrey, S. S., Pegram, M. D., & Matin, A. C. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0827 · Cited by 181 · see citing works
Biomedical applications of mRNA nanomedicine
Xiong, Q., Lee, G. Y., Ding, J., Li, W., & Shi, J. (2018) · Nano Research · doi:10.1007/s12274-018-2146-1 · Cited by 125 · see citing works
Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger.
Devoldere, J., Dewitte, H., De Smedt, S. C., & Remaut, K. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.07.009 · Cited by 112 · see citing works
Forterre, A. V., Wang, J.-H., Delcayre, A., Kim, K., Green, C., Pegram, M. D., Jeffrey, S. S., & Matin, A. C. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0928 · Cited by 62 · see citing works
- Authors
- Okumura, K., Nakase, M., Inui, M., Nakamura, S., Watanabe, Y., & Tagawa, T.
- Affiliations
- Mie University (JP)
- Sakakibara Onsen hospital (JP)
- Corresponding author
- Okumura, Kenya
- Venue
- The Journal of Gene Medicine
- Publisher
- Wiley
- Published
- 2008-06-19
- Volume
- 10
- Issue
- 8
- Pages
- 910-917
- ISSN
- 1099-498X (ISSN-L)
- 1521-2254
- OpenAlex
- W2092358502
- Cited by
- 31
- References
- 39
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 1 · 2013: 1 · 2012: 2
- FWCI
- 0.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Gene Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- Bax, cationic liposomes, lipofection, melanoma, apoptosis, caspase-3, tumor growth inhibition, tumor suppressor
- MeSH terms
- Humans, Liposomes, Melanoma, RNA, Messenger, Genetic Therapy, Cell Line, Tumor, bcl-2-Associated X Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review